Sildenafil Citrate Tablet
Product Images NDC 72789-406

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 72789-406). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789406 Label (72789406)

This is a product description for Sildenafil tablets, each containing 100mg of Sildenafil USP, to be taken as advised by a doctor. The tablets are film-coated with an oblong shape and blue color. Each pack contains 30 tablets with an expiration date of 10/2025. The manufacturer is PD-Rx Pharmaceuticals Incorporated based in Oklahoma City, OK. The GTIN code is 00372783406305, and the Lot number is H2A1. Remember to consult your doctor for medical advice on any potential side effects and report them to the FDA.*

FDA Label Image

Sildenafil-citrate-figure-1 (Sildenafil Citrate Figure 1)

FDA Label Image

Sildenafil-citrate-figure-2 (Sildenafil Citrate Figure 2)

The text appears to be a measurement or data table showing the change in mean standing systolic blood pressure from baseline. It seems to include numerical values and a figure indicating the data presentation format.*

FDA Label Image

Sildenafil-citrate-figure-3 (Sildenafil Citrate Figure 3)

This text provides data on the Mean Standing Systolic Blood Pressure Change from Baseline for different treatments such as Doxazosin, Placebo, and Silodosin. The recordings are shown at various time points.*

FDA Label Image

Sildenafil-citrate-figure-4 (Sildenafil Citrate Figure 4)

This text appears to show information related to a study or experiment involving the drug Doxazosin and its impact on standing systolic blood pressure. The graph presented in Figure 4 likely illustrates the mean standing systolic blood pressure change from baseline after the administration of Doxazosin at different dosages. The text also refers to specific dosage amounts and possibly the units of measurement.*

FDA Label Image

Sildenafil-citrate-figure-5 (Sildenafil Citrate Figure 5)

This text provides data on the mean Sildenafil plasma concentrations in healthy male volunteers.*

FDA Label Image

Sildenafil-citrate-figure-6 (Sildenafil Citrate Figure 6)

FDA Label Image

Sildenafil-citrate-figure-7 (Sildenafil Citrate Figure 7)

This text appears to be a table indicating percentages and numbers related to "Sildenafil citrate" in a certain context. The table includes values such as 8, 5, 8, 8, 4%, 63%, 2%, 35, 50, 100, 214, and 380. It seems to be part of a study or assessment regarding the usage or efficacy of Sildenafil citrate.*

FDA Label Image

Sildenafil-citrate-structure (Sildenafil Citrate Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.